RE:Trial Result Tables
To identify the results achieved by the 12 initially undertreated one has to revisit the MD&A for full year 2021 (dated 28 April 2022). Here on page 5 they first present the results for all patients then treated, incl. those from Phase Ib (first table), and next the results for the optimized cohort alone, this time excl. Phase Ib (second table). If you deduct from the first table the two CRs and one NR from Phase Ib, and also the results from the optimized cohort (second table), you are left with the results achieved by the undertreated cohort alone. These amount to: 4CRs and 2IRs at 90D, 3CRs and 2IRs at 180D, 3CRs and 1IR at 270D, 2CRs and 1IR at 260 days, and 2CRs and 1IR at 450D. At that point in time, all first 12 patients had been in the trial for way over 450 days, so the most reasonable assumption would seem to be that these results for the undertreated are complete and final.